Diagnosis, phenotype, and prevalence of polycystic ovary syndrome

被引：79

作者：

Carmina, Enrico

Azziz, Ricardo

机构：

[1] Univ Palermo, Dept Clin Med, I-90139 Palermo, Italy

[2] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA USA

[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA USA

[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA

来源：

FERTILITY AND STERILITY | 2006年 / 86卷

关键词：

polycystic ovary-syndrome; anovulation; hyperandrogenism;

D O I：

10.1016/j.fertnstert.2006.03.012

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

New diagnostic criteria for polycystic ovary syndrome (PCOS) suggested three main phenotypes: classic: (hyperandrogenism and anovulation), ovulatory, and normoandrogenic. However, it is unclear whether the normoandragenic phenotype actually represents :PCOS: Overall, 6% to 8% of reproductive-aged women suffer, from PCOS, making this disorder one of the most common endocrine abnormalities.

引用

页码：S7 / S8

页数：2

共 8 条

[1] The prevalence and features of the polycystic ovary syndrome in an unselected population
Azziz, R
Woods, KS
Reyna, R
Key, TJ
Knochenhauer, ES
Yildiz, BO
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2745 - 2749
[2] Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters
Carmina, E
Chu, MC
Longo, RA
Rini, GB
Lobo, RA
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) : 2545 - 2549
[3] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
Chang, J
Azziz, R
Legro, R
Dewailly, D
Franks, S
Tarlatzis, BC
Fauser, B
Balen, A
Bouchard, P
Dahlgren, E
Devoto, L
Diamanti, E
Dunaif, A
Filicori, M
Homburg, R
Ibanez, L
Laven, J
Magoffin, D
Nestler, J
Norman, RJ
Pasquali, R
Pugeat, M
Strauss, J
Tan, S
Taylor, A
Wild, R
Wild, S
Ehrmann, D
Lobo, R
[J]. FERTILITY AND STERILITY, 2004, 81 (01) : 19 - 25
[4] Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups
Chang, WY
Knochenhauer, ES
Bartolucci, AA
Azziz, R
[J]. FERTILITY AND STERILITY, 2005, 83 (06) : 1717 - 1723
[5] HOW COMMON ARE POLYCYSTIC OVARIES IN NORMAL WOMEN AND WHAT IS THEIR SIGNIFICANCE FOR THE FERTILITY OF THE POPULATION
CLAYTON, RN
OGDEN, V
HODGKINSON, J
WORSWICK, L
RODIN, DA
DYER, S
MEADE, TW
[J]. CLINICAL ENDOCRINOLOGY, 1992, 37 (02) : 127 - 134
[6] HYPERSECRETION OF ANDROSTENEDIONE BY ISOLATED THECAL CELLS FROM POLYCYSTIC OVARIES
GILLINGSMITH, C
WILLIS, DS
BEARD, RW
FRANKS, S
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (04) : 1158 - 1165
[7] Polycystic ovary syndrome in Mexican-Americans:: prevalence and association with the severity of insulin resistance
Goodarzi, MO
Quiñones, MJ
Azziz, R
Rotter, JI
Hsueh, WA
Yang, HY
[J]. FERTILITY AND STERILITY, 2005, 84 (03) : 766 - 769
[8] zawadzki JK., 1992, POLYCYSTIC OVARY SYN, P377

← 1 →